Literature DB >> 14642555

Follow-up care of women with an abnormal cytology in a low-resource setting.

Julia C Gage1, Catterina Ferreccio, Miguel Gonzales, Raul Arroyo, Militza Huivín, Sylvia C Robles.   

Abstract

STUDY
PURPOSE: We ascertained the follow-up care after an abnormal cytology (Papanicolaou) screening in the San Marti;n region of Perú and assessed the status of women who had not received adequate care. BASIC PROCEDURES: We identified women with an abnormal cytology and assessed their medical records, laboratory registries, death certificates and interviewed them at home. Re-screening, diagnosis and treatment were offered. MAIN
FINDINGS: Only 46 (25%) of the 183 women identified received appropriate follow-up care. At re-screening 31 (34%) had a normal result, 9 (10%) were diagnosed with CIN1 and 50 (56%) had CIN2 or worse. PRINCIPAL
CONCLUSIONS: In this setting, follow-up care after an abnormal cytology was very poor and could explain the lack of impact of cervical cancer screening. Women with an abnormal cytology constitute a high-risk group that should be a priority for health services.

Entities:  

Mesh:

Year:  2003        PMID: 14642555     DOI: 10.1016/j.cdp.2003.09.004

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  17 in total

1.  Reconsidering the feasibility of papanicolaou and alternative screening tests for low-resource countries.

Authors:  Vivien Davis Tsu
Journal:  Am J Public Health       Date:  2006-12-28       Impact factor: 9.308

2.  Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam.

Authors:  Proma Paul; Jennifer L Winkler; Rosario M Bartolini; Mary E Penny; Trinh Thu Huong; Le Thi Nga; Edward Kumakech; Emmanuel Mugisha; Jose Jeronimo
Journal:  Oncologist       Date:  2013-11-11

3.  An evaluation by midwives and gynecologists of treatability of cervical lesions by cryotherapy among human papillomavirus-positive women.

Authors:  Julia C Gage; Ana Cecilia Rodriguez; Mark Schiffman; Sydney Adadevoh; Manuel J Alvarez Larraondo; Bandit Chumworathayi; Sandra Vargas Lejarza; Luis Villegas Araya; Francisco Garcia; Scott R Budihas; Rodney Long; Hormuzd A Katki; Rolando Herrero; Robert D Burk; Jose Jeronimo
Journal:  Int J Gynecol Cancer       Date:  2009-05       Impact factor: 3.437

4.  Socioeconomic determinants of cervical cancer screening in Latin America.

Authors:  Samir Soneji; Natsu Fukui
Journal:  Rev Panam Salud Publica       Date:  2013-03

5.  Vaginal Suppositories Containing SHetA2 to Treat Cervical Dysplasia: Pharmacokinetics of Daily Doses and Preliminary Safety Profile.

Authors:  Sanjida Mahjabeen; Manolya Kukut Hatipoglu; Stanley D Kosanke; David Garcia-Contreras; Doris M Benbrook; Lucila Garcia-Contreras
Journal:  J Pharm Sci       Date:  2020-02-27       Impact factor: 3.534

6.  Cervical cancer prevention program in Jakarta, Indonesia: See and Treat model in developing country.

Authors:  Laila Nuranna; Mohamad Farid Aziz; Santoso Cornain; Gatot Purwoto; Sigit Purbadi; Setyawati Budiningsih; Budiningsih Siregar; Alexander Arnold Willem Peters
Journal:  J Gynecol Oncol       Date:  2012-07-02       Impact factor: 4.401

Review 7.  The challenge of cancer in middle-income countries with an ageing population: Mexico as a case study.

Authors:  Ajay Aggarwal; Karla Unger-Saldaña; Grant Lewison; Richard Sullivan
Journal:  Ecancermedicalscience       Date:  2015-05-07

8.  [Interest in visual inspection with acetic acid and Lugol iodine with colposcope in screening of cervical lesions in Gabon].

Authors:  Édith Mpiga; Mahinè Ivanga; Ismaël Hervé Koumakpayi; Corinne Engohan-Aloghe; Junie Chansi Ankély; Ernest Belembaogo; Jean-François Meye
Journal:  Pan Afr Med J       Date:  2015-10-21

9.  Are we missing opportunities to prevent cervical cancer in HIV-infected women in India?

Authors:  Smita Joshi; Vinay Kulkarni; Raman Gangakhedkar; Rengaswamy Sankaranarayanan
Journal:  Indian J Med Res       Date:  2015-11       Impact factor: 2.375

10.  Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda.

Authors:  Jean Damascène Makuza; Sabin Nsanzimana; Marie Aimee Muhimpundu; Lydia Eleanor Pace; Joseph Ntaganira; David James Riedel
Journal:  Pan Afr Med J       Date:  2015-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.